Status:

COMPLETED

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

Lead Sponsor:

Obstetrix Medical Group

Conditions:

Preterm Delivery

Eligibility:

FEMALE

18-60 years

Phase:

PHASE4

Brief Summary

The hypothesis is that administration of two courses of antenatal corticosteroids, compared to one course, will show a 40% reduction in the incidence of composite neonatal morbidity in patients delive...

Detailed Description

This is a randomized double-blinded placebo-controlled trial. The objective of this study is to evaluate the impact of one versus two courses of antenatal steroids on the incidence of major neonatal m...

Eligibility Criteria

Inclusion

  • 25 to 32 6/7 weeks gestation
  • Singleton or twin gestation
  • Received 1st course of betamethasone prior to 30 weeks' gestation
  • Began 1st course of betamethasone at least 14 days prior to randomization
  • Risk of delivery in next 7 days due to either maternal or fetal complication (e.g. preterm labor, severe preeclampsia, IUGR, etc.)
  • Intact membranes

Exclusion

  • Known major fetal anomalies (eg: anencephaly, renal agenesis etc…)
  • High order multiple gestation (triplets or higher)
  • Cervical dilation \> 5 cm
  • Clinical chorioamnionitis prior to initiation of second course (two or more of the following; antepartum temperature \> 38ºC (100.4ºF), uterine tenderness, foul smelling vaginal discharge or amniotic fluid, maternal tachycardia (\>100beats/min), fetal tachycardia (\>160 beats/min), or white blood cell count \>20x109/L.define)
  • Ruptured membranes prior to initiation of second course of betamethasone
  • Already receiving corticosteroids for other conditions (e.g. Lupus, asthma)
  • Maternal condition contraindicating the use of steroids (e.g. HIV, active Tuberculosis)
  • Participation in conflicting study

Key Trial Info

Start Date :

November 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

437 Patients enrolled

Trial Details

Trial ID

NCT00201643

Start Date

November 1 2003

End Date

February 1 2008

Last Update

January 7 2015

Active Locations (22)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (22 locations)

1

Desert Good Samaritan Hospital

Mesa, Arizona, United States, 85202

2

Banner Good Sammaritan Hospital

Phoenix, Arizona, United States, 85006

3

Tucson Medical Center

Tucson, Arizona, United States, 85712

4

Saddleback Memorial Medical Center

Laguna Hills, California, United States, 92653